Effect of treatment with folic acid and vitamin B6 on lipid and homocysteine concentrations in patients with coronary artery disease.
Mark
László
L
Department of Internal Medicine II-Cardiology Pándy Kálmán Békés County Hospital, Gyula, Hungary. mark@pandy.hu
Erdei
Ferenc
F
Markizay
János
J
Kondacs
András
A
Katona
András
A
D000368:Aged; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D019587:Dietary Supplements; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage* / Q000097:blood; D005838:Genotype; D006397:Hematinics / Q000008:administration & dosage* / Q000097:blood; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D009154:Mutation; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D016896:Treatment Outcome; D025101:Vitamin B 6 / Q000008:administration & dosage* / Q000097:blood
D006397:Hematinics; D008055:Lipids; D006710:Homocysteine; D025101:Vitamin B 6; D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)